Related Experiment Videos
[Primary hypertrophic cardiomyopathies. Diagnosis and treatment]
X Marcaggi1, P Barraud, C Schandrin
1Service du Pr Cassagnes, CHRU, Clermont-Ferrand.
Insights
Hypertrophic cardiomyopathy (HCM) is a heart condition often missed in young individuals, posing a risk of sudden death. Early diagnosis and management, primarily medical, are crucial for affected patients.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by abnormal diastolic function and potential left ventricular outflow obstruction.
- Early diagnosis is critical due to sudden death risk in young patients and the social impact of misdiagnosis.
Purpose of the Study:
- To review the diagnostic and therapeutic approaches for hypertrophic cardiomyopathy.
- To highlight the importance of echocardiography and cardiac Doppler in HCM assessment.
Main Methods:
- Echocardiography for evaluating septal hypertrophy and mitral valve motion.
- Cardiac Doppler for assessing outflow tract obstruction, diastolic dysfunction, and valve regurgitation.
- Holter monitoring for identifying high-risk patients.
Main Results:
- Echocardiography and Doppler are key non-invasive tools for HCM diagnosis and follow-up.
- Identifying patients at high risk for sudden death is vital.
- Medical therapy, particularly Propranolol, is the primary treatment, with tailored dosages.
Conclusions:
- Accurate diagnosis of HCM is essential to prevent sudden death and avoid psychosocial handicaps.
- Non-invasive imaging techniques play a central role in managing HCM.
- Treatment strategies, though debated, focus on medical management and risk stratification.
Abstract:
Hypertrophic cardiomyopathy (HCM) is currently considered to be a condition characterised by abnormal diastolic function, sometimes associated with left ventricular outflow obstruction which appears to be a secondary phenomenon. It is important to avoid overlooking this diagnosis especially in young subjects, because of the risk of sudden death, but conversely, false positive diagnosis can result in a serious social and psychological handicap. Echocardiography has assumed a major role in the diagnosis and follow-up of HCM over the last decade. It allows analysis of the localisation, extension and severity of the septal hypertrophy and of the mechanism of systolic anterior motion of the mitral valve. Cardiac doppler completes the non-invasive assessment of this condition by demonstrating the presence or absence of outflow tract obstruction, evaluating diastolic dysfunction, and documenting mitral and occasionally aortic valve regurgitation. Only severely symptomatic patients who do not respond to high dose medical therapy and for whom surgery might be an option need cardiac catheterization. Strenuous physical activity and sport are not recommended in asymptomatic forms. It is vital to identify those patients at high risk of sudden death (family history of sudden death, 48 to 72 hour Holter monitoring). In the absence of silent arrhythmias, preventive therapy should be more general in patients under 30 years of age. Despite a better understanding of the disease, the indications of medical and surgical treatment remain controversial and poorly defined. Treatment is mainly medical with Propranolol as the drug of choice. The dosage has to be tailored for each individual patient.(ABSTRACT TRUNCATED AT 250 WORDS)